Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × cannabichromene × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 736 Cisplatin 685 Gemcitabine 638 Bevacizumab 611 Carboplatin 603 Paclitaxel 601 Docetaxel 566 Radiotherapy 534 Fluorouracil 400 Oxaliplatin 384 Rituximab 368 Doxorubicin 357 Capecitabine 341 Filgrastim 333 Etoposide 327 Dexamethasone 311 Irinotecan 306 pembrolizumab 272 Leucovorin 271 Cetuximab 266 Cytarabine 241 Erlotinib Hydrochloride 231 Prednisone 225 Trastuzumab 224 Bortezomib 222 Nivolumab 220 Vincristine 219 Methotrexate 205 Pemetrexed 199 fludarabine phosphate 195

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06533657 2026-04-21

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Completed

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡